Bibliometric Analyses of Global Output on Neuromyelitis Optica Spectrum Disorder

Overview

Journal Oman J Ophthalmol

Specialty Ophthalmology

Date 2023 Aug 21

PMID 37602166

Authors

Carlos Quispe-Vicuna

Miguel Cabanillas-Lazo

Cesar Mauricio-Vilchez

Arnaldo Munive-Degregori

John Barja-Ore

Frank Mayta-Tovalino

Affiliations

Soon will be listed here.

Abstract

Background: Neuromyelitis optica spectrum disorder (NMOSD) is a neuroimmune disease, i.e. under constant research. The aim of this bibliometric study is to perform a bibliometric indicator analysis of the worldwide academic production of NMOSD during the period 2017-2021.

Methods: A bibliographic search was assessed in the Scopus database to identify NMOSD-related articles published during the period 2017-2021. Collected publications were exported and analyzed in Scival (Elsevier). Bibliographic data were described through absolute values and percentages in descriptive tables. VOSviewer was used to visualize collaborative networks.

Results: A total of 1920 documents were collected, and the highest percentage of these belonged to the area of neurology. Friedemann Paul was the author with the highest scientific production, but Brian Weinshenker had the greatest impact worldwide. Three of the institutions with the highest production were North American. Multiple sclerosis and related disorders were the journal with the highest production of publications. Most papers were published in Q1 or Q2 journals.

Conclusion: NMOSD-related articles are mostly published in first and second quartile journals, which would reflect a high interest of the scientific community. Publications with international collaboration reported a higher impact. Although African and South American regions have considerable prevalence of this disease, they do not have institutions with high productivity developing research on this disease.

References

Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D . Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the.... Bone Marrow Transplant. 2019; 55(2):283-306. PMC: 6995781. DOI: 10.1038/s41409-019-0684-0. View

Mariotto S, Mantovani A . Scientific productivity in neurology: impact of the socio-economic status. Neurol Sci. 2021; 42(4):1563-1566. DOI: 10.1007/s10072-020-04893-6. View

Wu Y, Zhong L, Geng J . Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models. Mult Scler Relat Disord. 2018; 27:412-418. DOI: 10.1016/j.msard.2018.12.002. View

Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85(2):177-89. PMC: 4515040. DOI: 10.1212/WNL.0000000000001729. View

Falagas M, Pitsouni E, Malietzis G, Pappas G . Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2007; 22(2):338-42. DOI: 10.1096/fj.07-9492LSF. View

Lennon V, Wingerchuk D, Kryzer T, Pittock S, Lucchinetti C, Fujihara K . A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364(9451):2106-12. DOI: 10.1016/S0140-6736(04)17551-X. View

Li T, Ho Y, Li C . Bibliometric analysis on global Parkinson's disease research trends during 1991-2006. Neurosci Lett. 2008; 441(3):248-52. DOI: 10.1016/j.neulet.2008.06.044. View

Hacohen Y, Mankad K, Chong W, Barkhof F, Vincent A, Lim M . Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology. 2017; 89(3):269-278. DOI: 10.1212/WNL.0000000000004117. View

Espiritu A, Leochico C, Separa K, Jamora R . Scientific impact of multiple sclerosis and neuromyelitis optica spectrum disorder research from Southeast Asia: A bibliometric analysis. Mult Scler Relat Disord. 2019; 38:101862. DOI: 10.1016/j.msard.2019.101862. View

10.

Lana-Peixoto M, Talim N, Pedrosa D, Macedo J, Santiago-Amaral J . Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil. Mult Scler Relat Disord. 2021; 50:102807. DOI: 10.1016/j.msard.2021.102807. View

11.

Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A . Neuromyelitis optica spectrum disorders. Clin Med (Lond). 2019; 19(2):169-176. PMC: 6454358. DOI: 10.7861/clinmedicine.19-2-169. View

12.

Jarius S, Wildemann B, Paul F . Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014; 176(2):149-64. PMC: 3992027. DOI: 10.1111/cei.12271. View

13.

Badri N, Teleb M, Syed S, Wardi M, Porres-Aguilar M, Cruz-Flores S . Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male. Case Rep Neurol. 2016; 8(2):102-7. PMC: 4924463. DOI: 10.1159/000446105. View

14.

Cree B, Bennett J, Kim H, Weinshenker B, Pittock S, Wingerchuk D . Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet. 2019; 394(10206):1352-1363. DOI: 10.1016/S0140-6736(19)31817-3. View

15.

Kim J, Kim J, Park K, Kim Y, Yoon D, Bae J . Top-100 cited articles on Guillain-Barré syndrome: a bibliometric analysis. J Peripher Nerv Syst. 2016; 21(4):329-338. DOI: 10.1111/jns.12188. View

16.

Alvarenga M, Schimidt S, Alvarenga R . Epidemiology of neuromyelitis optica in Latin America. Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317730098. PMC: 5617096. DOI: 10.1177/2055217317730098. View

17.

Papp V, Magyari M, Aktas O, Berger T, Broadley S, Cabre P . Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. Neurology. 2020; 96(2):59-77. PMC: 7905781. DOI: 10.1212/WNL.0000000000011153. View

18.

Levy M, Fujihara K, Palace J . New therapies for neuromyelitis optica spectrum disorder. Lancet Neurol. 2020; 20(1):60-67. DOI: 10.1016/S1474-4422(20)30392-6. View

19.

Nunes A, Fonseca A, Pinto F . Devic's syndrome in aquaporin-4 antibody negative patient. What we need to know …. GMS Ophthalmol Cases. 2016; 4:Doc09. PMC: 5015616. DOI: 10.3205/oc000022. View

20.

Alarcon-Ruiz C, Diaz-Barrera M, Vera-Monge V, Alva-Diaz C, Metcalf T . A Bibliometric Analysis of the Latin American Research on Stroke 2003-2017. World Neurosurg. 2019; 129:e545-e554. DOI: 10.1016/j.wneu.2019.05.212. View